Dicot Pharma AB (STO:DICOT)
0.2542
+0.0148 (6.18%)
At close: Sep 3, 2026
Dicot Pharma AB Market Cap
Dicot Pharma AB has a market cap or net worth of 881.74 million as of September 4, 2026. Its market cap has decreased by -52.30% in one year.
Market Cap
881.74M
Enterprise Value
633.34M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.25
ChartMarket Cap Chart
Since June 20, 2018, Dicot Pharma AB's market cap has increased from 63.22M to 881.74M, an increase of 1,294.78%. That is a compound annual growth rate of 37.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 881.74M | 42.94% |
| Dec 30, 2025 | 616.87M | 43.01% |
| Dec 30, 2024 | 431.35M | 65.92% |
| Dec 29, 2023 | 259.98M | 464.37% |
| Dec 30, 2022 | 46.07M | -35.49% |
| Dec 30, 2021 | 71.41M | 56.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cereno Scientific AB | 1.36B |
| Nanexa AB | 1.14B |
| EQL Pharma AB | 761.86M |
| Cinclus Pharma Holding AB | 630.12M |
| Moberg Pharma AB | 531.26M |
| Orexo AB | 525.92M |
| Enzymatica AB | 445.42M |
| Klaria Pharma Holding AB (publ.) | 156.19M |